Brief: Mannkind Corp Says Inhaled Insulin Is As Effective As Usual Care For Adults Living With T1D Meeting Primary Endpoint
22/06/2024 13:03
June 22 (Reuters) - MannKind Corp MNKD.O :
* MANNKIND CORP - INHALED INSULIN IS AS EFFECTIVE AS USUAL
CARE
FOR ADULTS LIVING WITH T1D MEETING PRIMARY ENDPOINT
Source text for Eikon: ID:nGNXMc7JP
Further company coverage: MNKD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MannKind
See all newsBrief: MannKind Enters Data-Rich Development Period With Completion Of Randomization In Phase 1B Inflo-1 Study And Enrollment Of First Patient In Phase 2 Inflo-2 Trial For Nintedanib Dpi In Patients With Ipf
U.S. STOCKS ON THE MOVE-Dell, Gap, Costco
MannKind rises after FDA approves inhaled insulin for children
US FDA approves MannKind's inhaled insulin for children (updated)
US FDA approves MannKind's inhaled insulin for children